English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine Clinical Trials
Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study
Mar 28, 2024 14:42 HKT
Essex Bio-Technology Posts Sound 2023 Annual Financial Results, Revenue Up 29.5%, Profit Up 22.1%
Mar 18, 2024 21:30 HKT
LYC Healthcare Reports Strong Q3 FY2024 Results of RM36.0 Million
Feb 28, 2024 09:34 HKT
Avance Clinical CEO Talks with SCRIP about US Biotech Sector "Green Shoots" and a New CRO Report
Feb 28, 2024 08:00 HKT
Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner
Jan 12, 2024 16:00 HKT
Avance Clinical Invited to Brief 45 Korean Biotechs on Their GlobalReady Drug Development Pathway from Korea and Australia to the US
Oct 19, 2023 09:00 HKT
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies
Aug 28, 2023 19:30 HKT
WholisticResearch Reveals the Best Nootropics of 2023
Aug 18, 2023 06:00 HKT
Asensus Surgical Continues to Spearhead Innovations and Growth in Surgical Robotics
Aug 17, 2023 21:00 HKT
Essex Bio-Technology Posts Sound 2023 Interim Financial Results, Revenue Up 37.1%, Profit Up 22%
Aug 16, 2023 19:06 HKT
The phase 1/2 clinical trial of Bevacizumab for treatment of Ophthalmic Diseases completed
Jul 26, 2023 18:58 HKT
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies
Jul 24, 2023 19:30 HKT
RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP) Platform
Jul 20, 2023 16:00 HKT
ADICON Holdings Limited One of the Top Three ICL Service Providers in China is Successfully Listed on Main Board of SEHK
Jun 30, 2023 14:25 HKT
ADICON Announces Proposed Listing on the Main Board of The Stock Exchange of Hong Kong at an Offer Price of HK$12.32 Per Share
Jun 19, 2023 11:37 HKT
Asensus Shares First Quarter Results and Future Plans
Jun 01, 2023 21:40 HKT
Avance Clinical at ASCO & BIO 2023: Early Phase Oncology Trials Increasingly Elaborate and Demand More Patients
May 30, 2023 10:00 HKT
Avance Clinical Joins Global Health Summit Campaign for Faster Access to Life-Changing and Life-Saving Therapies
May 25, 2023 09:00 HKT
EC Healthcare Signs Sustainability-Linked Syndicated Facility, A Ground-breaking Achievement in Hong Kong Healthcare Industry
May 10, 2023 11:52 HKT
Avance Clinical CEO Joins Global BioPharma Panel for Evolution Europe Summit 2023
Apr 18, 2023 11:00 HKT
Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: